<DOC>
	<DOC>NCT01616485</DOC>
	<brief_summary>The objective of this study is to evaluate the hemodynamic response to a sublingual dose of glyceryl trinitrate in subjects receiving oral TA-1790, sildenafil citrate, and placebo.</brief_summary>
	<brief_title>Study to Evaluate Hemodynamic Response to to a Sublingual Dose of Glyceryl Trinitrate in Subjects Receiving TA-1790, Sildenafil Citrate, and Placebo</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<mesh_term>Nitroglycerin</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Provide written informed consent Willing to comply with all study requirements and clinic schedules Male between 30 to 60 years of age Nonsmoker No history of alcohol abuse Normal screening laboratory values Allergy or hypersensitive to PDE5 inhibitors Evidence of clinically significant disease Supine systolic/diastolic blood pressure level History of cardiovascular disease Previously participated in TA1790 within the past 30 days</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>